Does APIXABAN Cause Product dose omission? 347 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 347 reports of Product dose omission have been filed in association with APIXABAN (ELIQUIS). This represents 0.2% of all adverse event reports for APIXABAN.
347
Reports of Product dose omission with APIXABAN
0.2%
of all APIXABAN reports
2
Deaths
55
Hospitalizations
How Dangerous Is Product dose omission From APIXABAN?
Of the 347 reports, 2 (0.6%) resulted in death, 55 (15.9%) required hospitalization, and 4 (1.2%) were considered life-threatening.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 347 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which APIXABAN Alternatives Have Lower Product dose omission Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ